Literature DB >> 25542586

Gene expression changes in serotonin, GABA-A receptors, neuropeptides and ion channels in the dorsal raphe nucleus of adolescent alcohol-preferring (P) rats following binge-like alcohol drinking.

Jeanette N McClintick1, William J McBride2, Richard L Bell2, Zheng-Ming Ding2, Yunlong Liu3, Xiaoling Xuei1, Howard J Edenberg4.   

Abstract

Alcohol binge-drinking during adolescence is a serious public health concern with long-term consequences. We used RNA sequencing to assess the effects of excessive adolescent ethanol binge-drinking on gene expression in the dorsal raphe nucleus (DRN) of alcohol preferring (P) rats. Repeated binges across adolescence (three 1h sessions across the dark-cycle per day, 5 days per week for 3 weeks starting at 28 days of age; ethanol intakes of 2.5-3 g/kg/session) significantly altered the expression of approximately one-third of the detected genes. Multiple neurotransmitter systems were altered, with the largest changes in the serotonin system (21 of 23 serotonin-related genes showed decreased expression) and GABA-A receptors (8 decreased and 2 increased). Multiple neuropeptide systems were also altered, with changes in the neuropeptide Y and corticotropin-releasing hormone systems similar to those associated with increased drinking and decreased resistance to stress. There was increased expression of 21 of 32 genes for potassium channels. Expression of downstream targets of CREB signaling was increased. There were also changes in expression of genes involved in inflammatory processes, axonal guidance, growth factors, transcription factors, and several intracellular signaling pathways. These widespread changes indicate that excessive binge drinking during adolescence alters the functioning of the DRN and likely its modulation of many regions of the central nervous system, including the mesocorticolimbic system.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alcoholism; CREB; GABA-A receptors; Inflammation; Neuropeptides; Serotonin

Mesh:

Substances:

Year:  2014        PMID: 25542586      PMCID: PMC4302739          DOI: 10.1016/j.pbb.2014.12.007

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  91 in total

Review 1.  Adolescent alcohol use: risks and consequences.

Authors:  E Jane Marshall
Journal:  Alcohol Alcohol       Date:  2014-01-08       Impact factor: 2.826

Review 2.  Animal models of alcoholism: neurobiology of high alcohol-drinking behavior in rodents.

Authors:  W J McBride; T K Li
Journal:  Crit Rev Neurobiol       Date:  1998

3.  Substance-specific and shared transcription and epigenetic changes in the human hippocampus chronically exposed to cocaine and alcohol.

Authors:  Zhifeng Zhou; Qiaoping Yuan; Deborah C Mash; David Goldman
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-04       Impact factor: 11.205

4.  The reinforcing actions of a serotonin-3 receptor agonist within the ventral tegmental area: evidence for subregional and genetic differences and involvement of dopamine neurons.

Authors:  Zachary A Rodd; Victoria E Gryszowka; Jamie E Toalston; Scott M Oster; Dong Ji; Richard L Bell; William J McBride
Journal:  J Pharmacol Exp Ther       Date:  2007-02-26       Impact factor: 4.030

5.  Genome-wide search for replicable risk gene regions in alcohol and nicotine co-dependence.

Authors:  Lingjun Zuo; Fengyu Zhang; Heping Zhang; Xiang-Yang Zhang; Fei Wang; Chiang-Shan R Li; Lingeng Lu; Jiang Hong; Lin Lu; John Krystal; Hong-Wen Deng; Xingguang Luo
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2012-04-04       Impact factor: 3.568

Review 6.  Interactions between NPY and CRF in the amygdala to regulate emotionality.

Authors:  Tammy J Sajdyk; Anantha Shekhar; Donald R Gehlert
Journal:  Neuropeptides       Date:  2004-08       Impact factor: 3.286

7.  Alcohol intake in high alcohol drinking (HAD) rats is suppressed by FG5865, a novel 5-HT1A agonist/5-HT2 antagonist.

Authors:  T A Long; G W Kalmus; A Björk; R D Myers
Journal:  Pharmacol Biochem Behav       Date:  1996-01       Impact factor: 3.533

Review 8.  Orexin receptors: multi-functional therapeutic targets for sleeping disorders, eating disorders, drug addiction, cancers and other physiological disorders.

Authors:  Tian-Rui Xu; Yang Yang; Richard Ward; Linghuan Gao; Ying Liu
Journal:  Cell Signal       Date:  2013-08-01       Impact factor: 4.315

9.  Gene expression in the ventral tegmental area of 5 pairs of rat lines selectively bred for high or low ethanol consumption.

Authors:  William J McBride; Mark W Kimpel; Jeanette N McClintick; Zheng-Ming Ding; Petri Hyytia; Giancarlo Colombo; Howard J Edenberg; Lawrence Lumeng; Richard L Bell
Journal:  Pharmacol Biochem Behav       Date:  2012-05-10       Impact factor: 3.533

10.  Addiction is a Reward Deficit and Stress Surfeit Disorder.

Authors:  George F Koob
Journal:  Front Psychiatry       Date:  2013-08-01       Impact factor: 4.157

View more
  22 in total

1.  Chronic Ethanol During Adolescence Impacts Corticolimbic Dendritic Spines and Behavior.

Authors:  Nicholas J Jury; Gabrielle A Pollack; Meredith J Ward; Jessica L Bezek; Alexandra J Ng; Courtney R Pinard; Hadley C Bergstrom; Andrew Holmes
Journal:  Alcohol Clin Exp Res       Date:  2017-06-14       Impact factor: 3.455

2.  mTORC1 pathway is involved in the kappa opioid receptor activation-induced increase in excessive alcohol drinking in mice.

Authors:  Yan Zhou; Yupu Liang; Mary Jeanne Kreek
Journal:  Pharmacol Biochem Behav       Date:  2020-05-26       Impact factor: 3.533

3.  Effects of chronic intermittent ethanol exposure and withdrawal on neuroblastoma cell transcriptome.

Authors:  Jeanette N McClintick; Kriti Thapa; Yunlong Liu; Xiaoling Xuei; Howard J Edenberg
Journal:  Alcohol       Date:  2020-01-07       Impact factor: 2.405

4.  MicroRNA-34a Regulates the Depression-like Behavior in Mice by Modulating the Expression of Target Genes in the Dorsal Raphè.

Authors:  Luisa Lo Iacono; Donald Ielpo; Alessandra Accoto; Matteo Di Segni; Lucy Babicola; Sebastian Luca D'Addario; Fabio Ferlazzo; Tiziana Pascucci; Rossella Ventura; Diego Andolina
Journal:  Mol Neurobiol       Date:  2019-09-03       Impact factor: 5.590

Review 5.  A Genetic Animal Model of Alcoholism for Screening Medications to Treat Addiction.

Authors:  R L Bell; S Hauser; Z A Rodd; T Liang; Y Sari; J McClintick; S Rahman; E A Engleman
Journal:  Int Rev Neurobiol       Date:  2016-03-21       Impact factor: 3.230

Review 6.  Rat animal models for screening medications to treat alcohol use disorders.

Authors:  Richard L Bell; Sheketha R Hauser; Tiebing Liang; Youssef Sari; Antoniette Maldonado-Devincci; Zachary A Rodd
Journal:  Neuropharmacology       Date:  2017-02-16       Impact factor: 5.250

7.  Peri-adolescent alcohol consumption increases sensitivity and dopaminergic response to nicotine during adulthood in female alcohol-preferring (P) rats: Alterations to α7 nicotinic acetylcholine receptor expression.

Authors:  Robert A Waeiss; Christopher P Knight; Gustavo B Carvajal; Richard L Bell; Eric A Engleman; William J McBride; Sheketha R Hauser; Zachary A Rodd
Journal:  Behav Brain Res       Date:  2019-08-29       Impact factor: 3.332

Review 8.  Pharmacotherapeutic management of co-morbid alcohol and opioid use.

Authors:  Lauren E Hood; Jonna M Leyrer-Jackson; M Foster Olive
Journal:  Expert Opin Pharmacother       Date:  2020-02-27       Impact factor: 3.889

Review 9.  Alcohol and violence: neuropeptidergic modulation of monoamine systems.

Authors:  Klaus A Miczek; Joseph F DeBold; Lara S Hwa; Emily L Newman; Rosa M M de Almeida
Journal:  Ann N Y Acad Sci       Date:  2015-08-18       Impact factor: 5.691

10.  Gene Expression Changes in Glutamate and GABA-A Receptors, Neuropeptides, Ion Channels, and Cholesterol Synthesis in the Periaqueductal Gray Following Binge-Like Alcohol Drinking by Adolescent Alcohol-Preferring (P) Rats.

Authors:  Jeanette N McClintick; William J McBride; Richard L Bell; Zheng-Ming Ding; Yunlong Liu; Xiaoling Xuei; Howard J Edenberg
Journal:  Alcohol Clin Exp Res       Date:  2016-04-08       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.